The programmatic hemosorption in the comprehensive treatment of atherosclerosis of various localization. Hemosorption in the treatment of atherosclerosis.
The inclusion of hemosorption through activated coals into the comprehensive treatment of 580 patients sick with atherosclerosis has made it possible to achieve a positive clinical effect among 81 per cent of the patients sick with the ischemic heart disease, 79 per cent of atherosclerotic discirculatory encephalopathy and 76 per cent of obliterating atherosclerosis of lower limbs. The positive dynamics is especially visible among patients who are administered the programmatic hemosorption, making it possible over a long period of time (3-5 years) to sustain remission in the clinical state and the normal level of the lipids in the blood. The direct effect is expressed in the improved microcirculation, disappearance of the sludge-syndrome and the reduction of ischemic disorders. The remote effect of hemosorption is connected with the repeated removals of cholesterin of the atherogenic lipoproteids, which leads, we believe, to the interruption or even regression of the atherosclerotic process.
Markin
S S
SS
Scientific-Research Institute of Physico-Chemical Medicine, Ministry of Public Health of the Russian Federation, Moscow.
Nalivaiko
E S
ES
Khalilov
E M
EM
Moreino
M S
MS
Kaminka TYa
Fedin
A I
AI
Teterina
E B
EB
Belousov YuB
D001161:Arteriosclerosis / Q000097:blood / Q000628:therapy*; D002545:Brain Ischemia / Q000097:blood / Q000628:therapy; D003327:Coronary Disease / Q000097:blood / Q000628:therapy; D006464:Hemoperfusion; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000628:therapy; D008055:Lipids / Q000097:blood
D008055:Lipids